Capital Goods Healthcare Sector

Prothena

Market Cap: US$398.3m

A late-stage clinical biotechnology company, focuses on discovery and development of novel therapies to treat diseases caused by protein dysregulation in the United States.

Verve Therapeutics

Market Cap: US$389.6m

A clinical-stage company, develops gene editing medicines for patients to treat cardiovascular disease in the United States.

AngioDynamics

Market Cap: US$389.4m

A medical technology company, engages in the design, manufacture, and sale of medical, surgical, and diagnostic devices for the use in treating peripheral vascular disease, and oncology and surgical settings in the United States and internationally.

Australian Clinical Labs

Market Cap: AU$602.4m

Provides pathology diagnostic services in Australia.

Oruka Therapeutics

Market Cap: US$386.0m

A clinical-stage biopharmaceutical company, focuses on developing novel monoclonal antibody therapeutics for psoriasis (PsO), and other inflammatory and immunology (I&I) indications.

Sana Biotechnology

Market Cap: US$378.9m

A biotechnology company, focuses on utilizing engineered cells as medicines in the United States.

Fulcrum Therapeutics

Market Cap: US$374.1m

A clinical-stage biopharmaceutical company, develops small molecules to improve the lives of patients with genetically defined diseases in the areas of high unmet medical need in the United States.

Rapport Therapeutics

Market Cap: US$373.0m

Operates as a clinical-stage biopharmaceutical company that focuses on the discovery and development of transformational small molecule medicines for patients suffering from central nervous system (CNS) disorders.

Faron Pharmaceuticals Oy

Market Cap: UK£275.4m

Operates as a clinical stage drug discovery and development company.

Atai Life Sciences

Market Cap: US$367.6m

A clinical-stage biopharmaceutical company, engages in the research, development, and commercialization of mental health treatments in the United States, Germany, and Canada.

UroGen Pharma

Market Cap: US$367.5m

Engages in the development and commercialization of solutions for urothelial and specialty cancers.

Zhengye Biotechnology Holding

Market Cap: US$367.3m

Engages in the research, development, manufacture, and sale of veterinary vaccines for livestock in China.

ClearPoint Neuro

Market Cap: US$367.1m

Operates as a medical device company primarily in the United States.

ORIC Pharmaceuticals

Market Cap: US$365.4m

A clinical-stage biopharmaceutical company, engages in the discovery and development of therapies to counter the resistance mechanisms cancers in the United States.

Emergent BioSolutions

Market Cap: US$365.3m

A life sciences company, provides preparedness and response solutions for accidental, deliberate, and naturally occurring public health threats in the United States.

Mereo BioPharma Group

Market Cap: US$364.1m

A biopharmaceutical company, develops and commercializes therapeutics for the treatment of oncology and rare diseases in the United Kingdom, the United States, and internationally.

TruBridge

Market Cap: US$363.3m

Provides healthcare solutions and services for community hospitals, clinics, and other healthcare systems in the United States and internationally.

NIOX Group

Market Cap: UK£270.8m

Engages in the design, development, and commercialization of medical devices for asthma diagnosis, monitoring, and management worldwide.

Benitec Biopharma

Market Cap: US$356.4m

A clinical-stage biotechnology company, focuses on the development of novel genetic medicines.

Absci

Market Cap: US$353.3m

Operates as a data-first generative artificial intelligence (AI) drug creation company in the United States.

SBC Medical Group Holdings

Market Cap: US$353.3m

Provides management services to cosmetic treatment centers in Japan, Vietnam, the United States, and Singapore.

Rigel Pharmaceuticals

Market Cap: US$352.1m

A biotechnology company, engages in discovering, developing, and providing therapies that enhance the lives of patients with hematologic disorders and cancer.

Alpha Teknova

Market Cap: US$349.5m

Produces critical reagents for the discovery, development, and commercialization of novel therapies, vaccines, and molecular diagnostics in the United States and internationally.

Nano-X Imaging

Market Cap: US$349.4m

Develops a commercial-grade tomographic imaging device with a digital X-ray source.

Checkpoint Therapeutics

Market Cap: US$348.5m

A commercial -stage immunotherapy and targeted oncology company, focuses on the acquisition, development, and commercialization of novel treatments for patients with solid tumor cancers in the United States and internationally.

Erasca

Market Cap: US$348.4m

A clinical-stage precision oncology company, focuses on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers.

Outset Medical

Market Cap: US$347.0m

A medical technology company, engages in the development of a hemodialysis system for hemodialysis in the United States.

Senseonics Holdings

Market Cap: US$346.8m

A commercial-stage medical technology company, focuses on development and manufacturing of continuous glucose monitoring (CGM) systems for people with diabetes in the United States and internationally.

Clinuvel Pharmaceuticals

Market Cap: AU$537.1m

A biopharmaceutical company, focuses on developing and commercializing treatments for patients with genetic, metabolic, systemic, and life-threatening disorders in Australia, Europe, the United States, Switzerland, and internationally.

Development Technologies

Market Cap: US$346.5m

Pegasus Pharmaceuticals Inc. manufactures and provides an advanced ECG system for the non-invasive screening of heart pathologies.

Humacyte

Market Cap: US$345.9m

Engages in the development and manufacture of off-the-shelf, implantable, and bioengineered human tissues for the treatment of diseases and conditions across a range of anatomic locations in multiple therapeutic areas.

Cidara Therapeutics

Market Cap: US$343.6m

Operates as a biotechnology company that focuses on developing targeted therapies for patients facing cancers and other serious diseases.

Cytek Biosciences

Market Cap: US$340.7m

A cell analysis solutions company, provides cell analysis tools that facilitates scientific advances in biomedical research and clinical applications.

Mayne Pharma Group

Market Cap: AU$526.5m

A specialty pharmaceutical company, manufactures and sells branded and generic pharmaceutical products in Australia, New Zealand, the United States, Canada, Europe, Asia, and internationally.

CytomX Therapeutics

Market Cap: US$335.6m

Operates as an oncology-focused biopharmaceutical company that focuses on developing novel conditionally activated biologics localized to the tumor microenvironment.

SNDL

Market Cap: US$334.5m

Engages in the production, distribution, and sale of cannabis products for the adult-use market in Canada.